March 19th, 2006
Genentech Has Its Mojo Working
Now here’s the kind of story we love to see (especially as the author owns 40 shares of DNA in his personal account.) 40-50% earnings growth in 2006 and 15 new products by 2010. Compare this with Pfizer and Merck, who are too busy selling the drugs they already have and fighting lawsuits to come up with any good new stuff. You know which $90 billion market cap we picked.
Like this article? Why not try out:
Topics: Stock Market | RSS
